Scientech Research’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
Scientech Research's NVAX Position: Q2 2026 in Review
Scientech Research sold out of Novavax (NVAX) in Q2 2026, closing a stake of 17,353 shares — an estimated $141K sold.
Scientech Research first reported a position in NVAX in Q1 2024 and held it in 5 quarters. The position peaked at $217K in Q2 2024. 269 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.
- Scientech Research reported no remaining Novavax position as of Q2 2026 after selling out during the quarter.
- Scientech Research sold 17,353 Novavax shares in Q2 2026, an estimated $141K.
- Scientech Research first reported a position in Novavax in Q1 2024 and held it in 5 quarters.
- Scientech Research's Novavax position peaked at $217K in Q2 2024.
- 269 funds tracked by Wall St. Rank held Novavax as of Q2 2026.
Based on Scientech Research's 13F filing for Q2 2026, filed 14 Aug 2026.